Download PDF
Thromb Haemost 2001; 86(04): 1077-1086
DOI: 10.1055/s-0037-1616536
Special Article
Schattauer GmbH

A Novel Tetrameric Venom Protein, Agglucetin from Agkistrodon acutus , Acts as a Glycoprotein Ib Agonist

Wen-Jeng Wang
1   Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
,
Tur-Fu Huang
1   Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
› Author Affiliations
Further Information

Publication History

Received 04 January 2001

Accepted after resubmission 18 June 2001

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

Summary

A novel platelet agglutination inducer, agglucetin, was purified from the Formosan Agkistrodon acutus snake venom. It migrated as a single band with an apparent molecular mass of 58.8 kDa and two distinct bands of 16.2/14.5 kDa under non-reducing and reducing conditions by SDS-PAGE, respectively. Further confirmed by FPLC, electrospray ionization mass spectrometry and 2D-PAGE, native agglucetin exists as a tetramer composed of disulfide-linked α1, α2, β1 and β2 subunits. Partial N-terminal sequence of agglucetin subunit showed a high degree of homology to those of C-type lectin-like glycoprotein (GP) Ib binding proteins. Functional studies showed that agglucetin, in the absence of von Willebrand factor (vWF), dose-dependently induced platelet agglutination and caused a negligible elevation of intracellular Ca+2 mobilization and thromboxane B2 formation in human platelet suspensions. Anti-GP Ib monoclonal antibodies (mAbs), AP1 or LJ-Ib1, specifically inhibited agglucetin-induced platelet agglutination in a dose-dependent manner. However, EDTA, arietin (a long chain RGD-containing disintegrin), 7E3 (an anti-GP IIb/IIIa mAb), heparin, hirudin, PGE1, or indomethacin exhibited no inhibitory effect on agglucetin-induced platelet agglutination. Furthermore, flow cytometric analysis revealed that FITC-agglucetin dose-dependently bound to human formalin-fixed platelets in a saturable manner, and its binding was specifically blocked by anti-GP Ib mAb. It is concluded that agglucetin, acts specifically on an epitope of platelet membrane GP Ib overlapping with that of AP1, causing platelet agglutination in a Ca+2- and GP IIb/IIIa-independent manner.

Keywords

C-type lectin-like venom proteins - Agkistrodon acutus - platelet agglutination - von Willebrand factor - glycoprotein Ib agonist
 

  • References

  • 1 Andrews RK, Berndt MC. Snake venom modulators of platelet adhesion receptors and their ligands. Toxicon 2000; 38: 775-91.
    CrossrefPubMedGoogle Scholar
  • 2 Markland FS. Snake venoms and the hemostatic system. Toxicon 1998; 36: 1749-800.
    CrossrefPubMedGoogle Scholar
  • 3 Ouyang C, Teng CM, Huang TF. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 1992; 30: 945-66.
    CrossrefPubMedGoogle Scholar
  • 4 Pirkle H, Stocker K. Thrombin-like enzymes from snake venoms: an inventory. Thromb Haemost 1991; 65: 444-50.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Fujimura Y, Kawasaki T, Titani K. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 1996; 76: 633-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Latallo ZS. Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes – a multicentre trial. Thromb Haemost 1983; 50: 604-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Coller BS. Monitoring platelet GP IIb/IIIa antagonist therapy. Circulation 1998; 97: 5-9.
    CrossrefPubMedGoogle Scholar
  • 8 Madan M, Berkowitz SD, Tcheng JE. Glycoprotein IIb/IIIa integrin blockade. Circulation 1998; 98: 2629-35.
    CrossrefPubMedGoogle Scholar
  • 9 Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet 1999; 353: 227-31.
    CrossrefPubMedGoogle Scholar
  • 10 Clemetson KJ, Clemetson JM. Platelet GPIb-V-IX complex – structure, function, physiology, and pathology. Semin Thromb Haemost 1995; 21: 130-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Clemetson KJ. Platelet activation: signal transduction via membrane receptors. Thromb Haemost 1995; 74: 111-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Clemetson KJ. Platelet GpIb-V-IX complex. Thromb Haemost 1997; 78: 266-70.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Ware J. Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost 1998; 79: 466-78.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Andrews RK, Berndt MC. Adhesion-dependent signalling and the initiation of haemostasis and thrombosis. Histol Histopathol 1998; 13: 837-44.
    PubMedGoogle Scholar
  • 15 Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, Lopez JA. Platelet glycoprotein Ib is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192: 193-204.
    CrossrefPubMedGoogle Scholar
  • 16 Usami Y, Fujimura Y, Suzuki M, Ozeki Y, Nishio K, Fukui H, Titani K. Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca . Proc Natl Acad Sci 1993; 90: 928-32.
    CrossrefPubMedGoogle Scholar
  • 17 Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Wille-brand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 1992; 31: 11144-51.
    CrossrefPubMedGoogle Scholar
  • 18 Peng M, Lu W, Kirby EP. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry 1991; 30: 11529-36.
    CrossrefPubMedGoogle Scholar
  • 19 Peng M, Lu W, Kirby EP. Characterization of three alboaggregins purified from Trimeresurus albolabris venom. Thromb Haemost 1992; 67: 702-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Kowalska MA, Tan L, Holt JC, Peng M, Karczewski J, Calvete JJ, Niewiarowski S. Alboaggregins A and B – structure and interaction with human platelets. Thromb Haemost 1998; 79: 609-13.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Usami Y, Suzuki M, Yoshida E, Sukurai Y, Hirano K, Kawsaki T, Fujimura Y, Titani K. Primary structure of alboaggregin-B purified from the venom of Trimeresurus albolabris . Biochem Biophys Res Commun 1996; 219: 727-33.
    CrossrefPubMedGoogle Scholar
  • 22 Sakurai Y, Fujimura Y, Kokubo T, Imamura K, Kawasaki T, Honda M, Suzuki M, Matsui T, Titani K, Yoshioka A. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein Ib-binding protein, mamushigin, from Agkistrodon halys blomhoffii venom. Thromb Haemost 1998; 79: 1199-207.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Fukuda K, Mizuno H, Atoda H, Morita T. Crystal structure of flavocetin-A, a platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like heterodimers. Biochemistry 2000; 39: 1915-23.
    CrossrefPubMedGoogle Scholar
  • 24 Liu CZ, Wang YW, Shen MC, Huang TF. Analysis of human platelet glycoprotein IIb-IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb Haemost 1994; 72: 919-25.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Huang TF, Wang WJ, Teng CM, Liu CS, Ouyang C. Purification and characterization of an antiplatelet peptide, arietin, from Bitis arietans venom. Biochim Biophys Acta 1991; 1074: 136-43.
    CrossrefPubMedGoogle Scholar
  • 26 Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspension of washed platelet from humans. Br J Haematol 1972; l (Suppl. 22) 193-204.
    PubMedGoogle Scholar
  • 27 Kirby EP, Mills DCB. The interaction of bovine factor VIII with human platelets. J Clin Invest 1975; 56: 491-502.
    CrossrefPubMedGoogle Scholar
  • 28 Pollock WK, Rink TJ. Thrombin and ionomycin can raise platelet cytosolic ca+2 to micromolar levels by discharge of internal Ca+2 stores: studies using fura-2. Biochem Biophys Res Commun 1986; 139: 308-14.
    CrossrefPubMedGoogle Scholar
  • 29 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca+2 indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
    PubMedGoogle Scholar
  • 30 Vlot AJ, Koppelman SJ, Bouma BN, Sixma JJ. Factor VIII and von Wille-brand factor. Thromb Haemost 1998; 79: 456-65.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Andrews RK, Lopez JA, Berndt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997; 29: 91-105.
    CrossrefPubMedGoogle Scholar
  • 32 Peng M, Lu W, Beviglia L, Niewiarowski S, Kirby EP. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 1993; 81: 2321-8.
    PubMedGoogle Scholar
  • 33 Peng M, Holt JC, Niewiarowski S. Isolation, characterization and amino acid sequence of echicetinsubunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. Biochem Biophys Res Commun 1994; 205: 68-72.
    CrossrefPubMedGoogle Scholar
  • 34 Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T. Isolation and characterization of Jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Haemost 1995; 74: 743-50.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Andrews RK, Kroll MH, Ward CM, Rose JW, Scarborough RM, Smith AI, Lopez JA, Berndt MC. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 1996; 35: 12629-39.
    CrossrefPubMedGoogle Scholar
  • 36 Chen YL, Tsai IH. Functional and sequence characterization of agkicetin, a new glycoprotein Ib antagonist isolated from Agkistrodon acutus venom. Biochem Biophys Res Commun 1995; 210: 472-7.
    CrossrefPubMedGoogle Scholar
  • 37 Kawasaki T, Taniuchi Y, Hisamichi N, Fujimura Y, Suzuki M, Titani K, Sakai Y, Kaku S, Satoh N, Takenaka T, Handa M, Sawai Y. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein Ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation. Biochem J 1995; 308: 947-53.
    CrossrefPubMedGoogle Scholar
  • 38 Taniuchi Y, Kawasaki T, Fujimura Y, Suzuki M, Titani K, Sakai Y, Kaku S, Hisamichi N, Satoh N, Takenaka T, Handa M, Sawai Y. Flavocein-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim Biophys Acta 1995; 1244: 331-8.
    CrossrefPubMedGoogle Scholar
  • 39 Yeh CH, Chang MC, Peng HC, Huang TF. Pharmacological characterization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist. Br J Pharm 2001; 132: 843-850.
    CrossrefPubMedGoogle Scholar
  • 40 Okita JR, Pidard D, Newman PJ, Montgomery RR, Kunicki TJ. On the association of glycoprotein Ib and actin-binding protein in human platelets. J Cell Biol 1985; 100: 317-21.
    CrossrefPubMedGoogle Scholar
  • 41 Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Wille-brand factor-binding domain of platelet membrane glycoprotein Ib – characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem 1986; 261: 12579-85.
    PubMedGoogle Scholar
  • 42 Kawasaki T, Fujimura Y, Usami Y, Suzuki M, Miura S, Sakurai Y, Makita K, Taniuchi Y, Hirano K, Titani K. Complete amino acid sequence and identification of the platelet glycoprotein Ib-binding site of jararaca GPIbBP, a snake venom protein isolated from Bothrops jararaca . J Biol Chem 1996; 271: 10635-9.
    CrossrefPubMedGoogle Scholar
  • 43 Polgar J, Magnenat EM, Peitsch MC, Wells TNC, Saqi MSA, Clemetson KJ. Amino acid sequence of thesubunit and computer modelling of theandsubunits of echicetin from the Echis carinatus . Biochem J 1997; 323: 533-7.
    CrossrefPubMedGoogle Scholar
  • 44 Ware J, Russel SR, Marchese P, Murata M, Mazzucato M, Marco LD, Ruggeri ZM. Point mutation in a leucine-rich repeat of platelet glycoprotein Ib resulting in the Bernard-Soulier syndrome. J Clin Invest 1993; 92: 1213-20.
    CrossrefPubMedGoogle Scholar